KEGG DRUG Database
KEGG DRUG is a comprehensive drug information resource for approved drugs in Japan, USA, and Europe unified based on the chemical structures and/or the chemical components, and associated with target, metabolizing enzyme, and other molecular interaction network information. All the marketed drugs in Japan, not only the prescription drugs but also the OTC drugs, are fully represented in KEGG DRUG and integrated with the package insert information (labels information). These include crude drugs and TCM (Tradictional Chinese Medicine) drugs.
Each KEGG DRUG entry is identified by the D number distinguishing the chemical structure of chemicals or the chemical component of mixtures. It is associated with the following information (see, for example, D01441 or Gleevec for the treatment of chronic myeloid leukemia).
Each KEGG DRUG entry is identified by the D number distinguishing the chemical structure of chemicals or the chemical component of mixtures. It is associated with the following information (see, for example, D01441 or Gleevec for the treatment of chronic myeloid leukemia).
- Generic names (associated with chemical structures, see details below)
- Representative trade names
- Links to FDA approved drug labels information in DailyMed
- Chemical structure, chemical component, peptide/polyketide sequence
- Target molecules in the context of KEGG pathway maps
- Drug metabolizing enzymes and transporters
- Other interacting molecules including genomic biomarkers, CYP inducers/inhibitors, etc.
- Adverse drug-drug interaction data (collected from the Japanese package inserts)
- Text description of activity and efficacy
- Therapeutic category, ATC code, and other drug classification information in BRITE hierarchy
- History of drug development represented as a KEGG DRUG structure map
- Links to outside databases
Drug Classification
For representation of efficacy and therapeutic use, different drug classification systems are maintained as part of the KEGG BRITE functional hierarchies. The first group is based on the established classification systems to which KEGG DRUG entries are manually assigned.
The classification may be examined with additional information on targets and metabolizing enzymes shown in a separate column.
The second group consists of additional classification systems developed by KEGG.
Category Classification Additional info Remark Prescription drug ATC Classification Target Enzyme ATC 2012 USP drug classification Target Enzyme v5.0 Therapeutic category of drugs in Japan Target Enzyme JP16 OTC drug
(Japan)Classification of Japanese OTC drugs Risk category of Japanese OTC drugs
Furthermore, the following information is provided.
Category Classification Remark Prescription drug Target-based classification Antiinfectives Antineoplastics Crude drug
(Japan)TCM drugs in Japan See also: KEGG ENVIRON Crude drugs in Japan
Labels information (in Japanese) of all marketed drugs in Japan is provided through the Japanese version of KEGG DRUG.
Category Information Prescription drug Drugs listed in the Japanese Pharmacopoeia OTC drug Rx-to-OTC switch list in Japan Rx-to-OTC switch list in the USA
KEGG DRUG Structure Maps
Many marketed drugs have been developed from lead compounds or existing drugs by introducing chemical structure transformations retaining the core chemical structures. KEGG DRUG structure maps graphically illustrate, in a manner similar to KEGG pathway maps, our knowledge on such drug development. They are in the Drug Development category of the KEGG PATHWAY database.
Generic Names and Trade Names
The chemical structure of a drug is identified by the standardized generic name, but the names can be different in different countries or organizations. The same structure may be called differently and the same name may mean different structures. To accomodate such differences the generic names are associated with the following codes in parentheses.
Selected trade names (TNs) are also given in each KEGG DRUG entry. More names may be found from the outside link to DailyMed, which provides FDA approved labels information of marketed drugs.
- JAN - Japanese Approved Name
- USAN - United States Adopted Name
- NF - National Formulary drug name
- INN - International Nonproprietary Name
- BAN - British Approved Name
- DCF - Dénomination commune française
- JP16 - Japanese Pharmacopoeia, 16th edition
- USP - United States Pharmacopeia
Selected trade names (TNs) are also given in each KEGG DRUG entry. More names may be found from the outside link to DailyMed, which provides FDA approved labels information of marketed drugs.
Last updated: January 13, 2012
